Nanofiber matrix* is a product that offers a novel approach to second intention healing after skin cancer or vascular surgery. Secondary intention healing is often chosen for wounds in mi...
This case describes a 65 year-old with T3N0M0 anal squamous cell cancer, treated with 5 weeks of capecitabine and mitomcyin chemoradiation, referred to wound care for persistent grade 3-4...
Introduction:Hidradenitis Suppurativa (HS) is a poorly understood disease that afflicts approximately 8.6 per 100,000 people a year in the US.1 Surgical excision of the infected skin and...
On March 11, 2020, the World Health Organization declared that COVID-19 met the definition of a pandemic. On that day, there were 3 COVID-19 patients hospitalized within our medical cent...
We present our experience using dehydrated human amnion/chorion membrane (dHACM) allograft as a novel adjunct therapy integrated into the treatment plan and restoration of a failed arteri...
Patients with diabetic foot ulcers (DFUs), in particular when unresponsive to standard wound care, face serious risks of severe complications, including infection and amputation. The mana...
This is a single centre, pilot randomised controlled trial (RCT) in patients with a DFU, with blinded outcome assessment. Patients were randomised in a 1:1 allocation ratio to either tre...
This randomized controlled trial examined the effect of frailty on success of wound granulation with a human acellular dermal matrix (DM)* and a bilayer bovine dermal matrix (BLM).
...
Lower-extremity surgically closed wounds in patients with diabetes could be severely affected by poor tissue oxygenation (1-2). Adverse events (AE) such as necrosis, dehiscence, or re-ope...
Diabetic foot ulcers (DFUs) continue to challenge wound care practitioners. They are prone to infection and increase the risk of lower extremity amputation. The aim of this study was to e...